386891004: Infliximab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Immunomodulator\...

\Tumor necrosis factor alpha inhibitor\Infliximab (substance)

\Immunosuppressant (substance)\Infliximab (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Tumor necrosis factor alpha inhibitor\Infliximab (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Gastrointestinal agent (substance)\Infliximab (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Immunosuppressant (substance)\Infliximab (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Monoclonal antibody\Infliximab (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Infliximab (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Infliximab (substance)

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Infliximab (substance)
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Infliximab (substance)
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Infliximab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Infliximab (substance)	Is a	anticorps monoclonal chimérique souris-humain d'isotype IgG	false	Inferred relationship	Some
Infliximab (substance)	Is a	Monoclonal antibody	true	Inferred relationship	Some
Infliximab (substance)	Is a	agent antirhumatismal	false	Inferred relationship	Some
Infliximab (substance)	Is a	Gastrointestinal agent (substance)	true	Inferred relationship	Some
Infliximab (substance)	Is a	Tumor necrosis factor alpha inhibitor	true	Inferred relationship	Some
Infliximab (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Tumor necrosis factor alpha inhibitor (disposition)	true	Inferred relationship	Some
Infliximab (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Murine-human monoclonal immunoglobulin G antibody	false	Inferred relationship	Some
Infliximab (substance)	Is a	Immunosuppressant (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing infliximab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Infliximab (substance)	Inferred relationship	Some	1
Infliximab 100mg powder for infusion solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Infliximab (substance)	Inferred relationship	Some
Infliximab 100mg/vial injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Infliximab (substance)	Inferred relationship	Some
Infliximab 100 mg powder for solution for injection vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Infliximab (substance)	Inferred relationship	Some
Infliximab therapy (procedure)	Direct substance	True	Infliximab (substance)	Inferred relationship	Some	2
Infliximab 100 mg powder for solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Infliximab (substance)	Inferred relationship	Some	1
Infliximab 100 mg powder for solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Infliximab (substance)	Inferred relationship	Some	1
Product containing infliximab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Infliximab (substance)	Inferred relationship	Some	1
Product containing only infliximab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Infliximab (substance)	Inferred relationship	Some	1
Product containing only infliximab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Infliximab (substance)	Inferred relationship	Some	1
Product containing precisely infliximab 120 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Infliximab (substance)	Inferred relationship	Some	1
Product containing precisely infliximab 120 milligram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Infliximab (substance)	Inferred relationship	Some	1
Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Infliximab (substance)	Inferred relationship	Some	1
Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Infliximab (substance)	Inferred relationship	Some	1
Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Infliximab (substance)	Inferred relationship	Some	1
Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Infliximab (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461069010	Infliximab (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481005012	Infliximab	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
52801000195117	infliximab	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
190161000077110	infliximab	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
67671000195116	Infliximab	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module